Sepracor To Increase Lunesta Promotional Spend After Pfizer Drops Indiplon
This article was originally published in The Pink Sheet Daily
Executive Summary
Sepracor plans to increase DTC, professional marketing programs to make up for the absence of Pfizer's initiatives to grow the sleep aid market.